BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/24/2026 5:54:48 AM | Browse: 90 | Download: 154
 |
Received |
|
2025-11-14 12:41 |
|
Peer-Review Started |
|
2025-11-17 00:35 |
|
First Decision by Editorial Office Director |
|
2025-12-24 10:29 |
|
Return for Revision |
|
2025-12-24 10:29 |
|
Revised |
|
2026-01-06 12:21 |
|
Publication Fee Transferred |
|
2026-01-08 01:32 |
|
Second Decision by Editor |
|
2026-02-13 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-13 04:11 |
|
Articles in Press |
|
2026-02-13 04:11 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-15 02:13 |
|
Publish the Manuscript Online |
|
2026-04-24 05:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Qiweizhigan granule ameliorates metabolic dysfunction-associated steatohepatitis by modulating the galectin 3/tumor necrosis factor receptor-associated factor 6-mediated ferroptosis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yu-Nuo Yang, Yun-Hong Sun, Ming-Zhe Zhu, Yi-Rong Wang, Meng Li, Kai Wang, Jing Ma, Li Zhang, Dan Hu, Wen-Jun Zhou, Guang Ji and Yan-Qi Dang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82530124 |
| Digestive Diseases Committee of the Chinese Association of Traditional Chinese Medicine-The Youth Empowerment Program |
No. 202557-006 |
| State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine |
No. LSLSKL20240127 |
|
| Corresponding Author |
Yan-Qi Dang, Institute of Digestive Diseases, China-Canada Center of Research for Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Fenglin Road Subdistrict, Shanghai 200032, China. yq_dang@shutcm.edu.cn |
| Key Words |
Qiweizhigan granule; Metabolic dysfunction-associated steatohepatitis; Galectin 3; Tumor necrosis factor receptor-associated factor 6; Ferroptosis |
| Core Tip |
This study reveals that galectin 3 plays a critical role in the progression of metabolic dysfunction-associated steatohepatitis by regulating ferroptosis through the tumor necrosis factor receptor-associated factor 6/glutathione peroxidase 4 axis. The traditional Chinese medicine Qiweizhigan granule significantly alleviates the progression of metabolic dysfunction-associated steatohepatitis by targeting the galectin 3/tumor necrosis factor receptor-associated factor 6/glutathione peroxidase 4 axis. |
| Publish Date |
2026-04-24 05:43 |
| Citation |
Yang YN, Sun YH, Zhu MZ, Wang YR, Li M, Wang K, Ma J, Zhang L, Hu D, Zhou WJ, Ji G, Dang YQ. Qiweizhigan granule ameliorates metabolic dysfunction-associated steatohepatitis by modulating the galectin 3/tumor necrosis factor receptor-associated factor 6-mediated ferroptosis. World J Gastroenterol 2026; 32(17): 116386 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i17/116386.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i17.116386 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
